DCDC2 promotes ICC proliferation, metastasis, and immune evasion by stabilizing ENO1, enhancing AKT phosphorylation, and increasing FGL1 levels, which impairs CD8+ T cell functionality. This evidence concerns the gene CD8A and intrahepatic cholangiocarcinoma.